These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18457524)

  • 1. Cystatin C: a potential target for Alzheimer's treatment.
    Levy E
    Expert Rev Neurother; 2008 May; 8(5):687-9. PubMed ID: 18457524
    [No Abstract]   [Full Text] [Related]  

  • 2. The emerging role of cystatins in Alzheimer's disease.
    Zerovnik E
    Bioessays; 2009 Jun; 31(6):597-9. PubMed ID: 19382231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?
    Carro E; Torres-Aleman I
    Expert Rev Neurother; 2004 Jan; 4(1):79-86. PubMed ID: 15853618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C modulates cerebral beta-amyloidosis.
    Kaeser SA; Herzig MC; Coomaraswamy J; Kilger E; Selenica ML; Winkler DT; Staufenbiel M; Levy E; Grubb A; Jucker M
    Nat Genet; 2007 Dec; 39(12):1437-9. PubMed ID: 18026102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M1 muscarinic agonists target major hallmarks of Alzheimer's disease--the pivotal role of brain M1 receptors.
    Fisher A
    Neurodegener Dis; 2008; 5(3-4):237-40. PubMed ID: 18322400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid imaging in Alzheimer's disease.
    Nordberg A
    Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's theory makes a splash.
    Schnabel J
    Nature; 2009 May; 459(7245):310. PubMed ID: 19458681
    [No Abstract]   [Full Text] [Related]  

  • 9. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Klunk WE; Mathis CA; Price JC; Lopresti BJ; DeKosky ST
    Brain; 2006 Nov; 129(Pt 11):2805-7. PubMed ID: 17071918
    [No Abstract]   [Full Text] [Related]  

  • 10. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
    Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synaptic Abeta hypothesis of Alzheimer disease.
    Tanzi RE
    Nat Neurosci; 2005 Aug; 8(8):977-9. PubMed ID: 16047022
    [No Abstract]   [Full Text] [Related]  

  • 12. Muscarinic receptors in Alzheimer's disease.
    Pavía J; de Ceballos ML; Sánchez de la Cuesta F
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():71-5. PubMed ID: 8899700
    [No Abstract]   [Full Text] [Related]  

  • 13. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclodextrins promote protein aggregation posing risks for therapeutic applications.
    Wang MS; Boddapati S; Sierks MR
    Biochem Biophys Res Commun; 2009 Aug; 386(3):526-31. PubMed ID: 19540204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.
    Kreft AF; Martone R; Porte A
    J Med Chem; 2009 Oct; 52(20):6169-88. PubMed ID: 19694467
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral amyloid angiopathy with the deposition of cystatin C (gamma-trace) and beta-protein.
    Fujihara S; Shimode K; Nakamura M; Kobayashi S; Tsunematsu T
    Prog Clin Biol Res; 1989; 317():939-44. PubMed ID: 2690129
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta amyloid's accomplice? Molecular hit man might help Alzheimer's protein take out brain's white matter.
    Leslie M
    Sci Aging Knowledge Environ; 2004 Jan; 2004(2):nf8. PubMed ID: 14724324
    [No Abstract]   [Full Text] [Related]  

  • 19. The amyloid cascade hypothesis.
    Korczyn AD
    Alzheimers Dement; 2008 May; 4(3):176-8. PubMed ID: 18631966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the CREB pathway for memory enhancers.
    Tully T; Bourtchouladze R; Scott R; Tallman J
    Nat Rev Drug Discov; 2003 Apr; 2(4):267-77. PubMed ID: 12669026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.